medipharm labs stock forecast 2025

MediPharm Labs (OTCQX:MEDIF) entered into a new white-label supply agreement with DanCann Pharma; marking its third supply agreement for the export of … 0.495. 5 Wall Street analysts have issued ratings and price targets for MediPharm Labs in the last 12 months. Medipharm Labs Corp is a OTC stock, trading under the symbol LABS-V on the (). MediPharm Labs Corp. () Stock Market info Recommendations: Buy or sell MediPharm Labs stock? As of 2021 June 14, Monday current price of MEDIF stock is 0.40010$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. MediPharm Labs stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Founded in 2015, MediPharm Labs specializes in the production of purified, pharmaceutical quality cannabis oil and concentrates and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard built clean rooms. Date Average price (≈) Minimum price (⇓) Maximum price (⇑) 2026 January: 2026-01-01: ≈ … ... 0.2025 (+7.03%) OILS.CN: 0.250 (+4.17%) CGC: 24.72 (+1.56%) WEED.TO: 29.63 (+0.47%) ... A measure of how much a stock or commodity has risen or fallen over a one-year period. MediPharm Labs is involved in all kinds of research and development, from equipment testing & modification, parameter testing for optimal methodologies, as well as formulation research. FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “MediPharm Labs First to Launch THC-Free, 99% Pure CBD Isolate Consumer Sized Crystal in Canada.” Medipharm Labs Corp. stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. MediPharm Labs Announces Voting Results From the 2021 Annual Meeting of Shareholders. Partnership validates MediPharm Labs’ GMP pharmaceutical-quality cannabis production and, combined with STADA’s 125-year heritage and experienced marketing and … BARRIE, Ontario, June 10, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS… The high price target for LABS is C$2.15 and the low price target for LABS … Their forecasts range from $1.50 to $15.00. Founded in 2015, MediPharm Labs specializes in the production of purified, pharmaceutical-quality cannabis oil and concentrates and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. The company generates revenue from Private label, White label, the Tolling process, and others. MediPharm Labs Announces Voting Results From the 2021 Annual Meeting of Shareholders. In the last year, there was no coverage of Medipharm Labs Corp published on Stockchase. Find real-time MEDIF - Medipharm Labs Corp stock quotes, company profile, news and forecasts from CNN Business. Founded in 2015, MediPharm Labs specializes in the production of purified, pharmaceutical quality cannabis oil and concentrates and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard built clean rooms. Stock Predictons by days: 2025 Search Stock, FX pair, Crypto, or Commodity... MediPharm Labs Corp. Stock Forecast and Price Prognosis Data for 2025 About MediPharm Labs Corp. Toronto Stock Market & Finance report, prediction for the future: You'll find the MediPharm Labs share forecasts, stock quote and buy / sell signals below.According to present data MediPharm Labs's LABS shares and potentially its market environment have been in bearish cycle last 12 months … MediPharm Labs Corp. () Stock Market info Recommendations: Buy or sell MediPharm Labs stock? MediPharm Labs Corp. Stock Forecast and Price Prognosis Data for 2026 . 2021 2022 . Is Medipharm Labs Corp a … CAD. Some of this growth can be attributed to … Stock Information Company Overview MediPharm Labs, a contract development and manufacturing company, brings a pharmaceutical perspective to the cannabis industry; working to internationally recognized pharma-quality standards, our cannabis API and derivative products are PURE, TRUSTED and PRECISELY DOSABLE for patients and end consumers. 04/08. MediPharm Labs Corp () Stock Market info Recommendations: Buy or sell MediPharm Labs stock? MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed cannabis products for its customers. For MediPharm Labs Corp. stock forecast 2025, 12 predictions are offered for each month of 2025 with average MediPharm Labs Corp. stock forecast of 0.4, a high forecast of 0.4, and a low forecast of 0.4. Each grant has a five-year term expiring July 13, 2025. MediPharm Labs Corp. (MEDIF) Other OTC - Other OTC Delayed Price. History; Forecast; Charts; Data; Market; Q&A; Comments > Page 1: MediPharm Labs Corp. (MEDIF) Forecast Charts . Each grant has a five-year term expiring July 31, 2025. About MediPharm Labs Corp. 6 Wall Street analysts have issued ratings and price targets for MediPharm Labs in the last 12 months. Delayed Toronto Stock Exchange - 04/09 03:36:00 pm. See MEDIPHARM LABS CORP (MEDIF) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. MediPharm Labs Completes Its First High THC Cannabis Oil Export to Peru. About the MediPharm Labs Corp. stock forecast. 8 equities research analysts have issued 12 month price objectives for FuelCell Energy's shares. Medipharm Labs Corp stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Market open. Wall Street Stock Market & Finance report, prediction for the future: You'll find the MediPharm Labs share forecasts, stock quote and buy / sell signals below. According to present data MediPharm Labs's MEDIF shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Partnership validates MediPharm Labs’ GMP pharmaceutical-quality cannabis production and, combined with STADA’s 125-year heritage and experienced marketing and sales platform, will meet the growing demand of the medical cannabis market, beginning in Germany – an estimated €1.5 billion market by 2025 Our strict manufacturing standards result in pharma-quality cannabis API and derivative products for patients and consumers that are pure, trusted and precisely dosable for patients and end consumers. This suggests that the stock has a possible downside of 20.7%. MediPharm Labs’ state-of-the-art cannabis extraction facility is Good Manufacturing Practices (GMP) Certified and designed with ISO standard cleanrooms and critical environments. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MediPharm Labs stock. View analyst ratings for MediPharm Labs or view top-rated stocks. As of 2:27PM EDT. MediPharm Labs: 93% sales growth ... (MSO) Cresco Labs is forecast to deliver 78% sales growth next year. Their average twelve-month price target is $1.25, predicting that the stock has a possible upside of 225.55%. Earnings Trend: LABS is unprofitable, and losses have increased over the past 5 years at a rate of 85.7% per year. GL. MediPharm Labs is positioned for growth in 2020 as Cannabis 2.0 products rollout in Canada and the company expands internationally having just obtained a GMP certification by the Therapeutic Goods Administration in Australia.The stock is down to near $1 despite these positive results. Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and p This suggests a possible upside of 135.4% from the stock's current price. MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. MediPharm Labs Corp Is Up 123% in 2019, With Room to Run Cannabis stocks have not lived up to all the hype this year. MediPharm Labs, which produces pharmaceutical-grade cannabis oil and concentrates, on Monday announced signing an exclusive supply agreement with pharma giant STADA Arzneimittel, a … MediPharm Labs, a contract development and manufacturing company, brings a pharmaceutical perspective to the cannabis industry; working to internationally recognized pharma-quality standards, our cannabis API and derivative products are PURE,… Past Earnings Growth Analysis. On average, they expect MediPharm Labs' share price to reach $1.25 in the next year. Their forecasts range from $0.75 to $1.75. Their forecasts range from C$0.50 to C$2.15. MediPharm Labs exports commercial shipment of medical cannabis products approved by the Australian Therapeutic Goods Administration (TGA) to patients in GermanyAn export milestone for the Australian cannabis industry as an export hubGermany is one of the most heavily regulated export markets in the world, this export milestone strengthens MediPharm Labs’ and Australia's position as a … On average, they anticipate FuelCell Energy's stock price to reach $9.10 in the next year. Their average twelve-month price target is C$1.13, predicting that the stock has a possible upside of 135.42%. 6 equities research analysts have issued 12-month price objectives for MediPharm Labs' shares. This suggests a possible upside of 219.4% from the stock's current price. BARRIE, Ontario, May 27, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced it launched its first wellness products in Quebec and shipped its first order of premium … It is usually referred to as or LABS-V Is Medipharm Labs Corp a buy or a sell? The high price target for MEDIF is $1.75 and the low price target for MEDIF is $0.75. Along with our suppliers and consultants, we are forging the next generation of cannabis science, technology, methodology and practice. On average, they anticipate MediPharm Labs' stock price to reach C$1.13 in the next twelve months. +4.21%. Some of its vape brands are Northern Lights, Blue Dream, 2:1 CBD:THC, Pink Kush and GG4. BARRIE, Ontario, April 01, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced STADA Arzneimittel AG (STADA), a leading European consumer health and generics company, and MediPharm Labs… Accelerating Growth: Unable to compare LABS's earnings growth over the past year to its 5-year average as it is currently unprofitable. MediPharm Labs (MEDIF) stock price prediction is 0 USD. The MediPharm Labs stock forecast is 0 USD for 2022 April 27, Wednesday. MediPharm Labs stock forecast, MEDIF price prediction: Buy or sell MediPharm Labs Corp. shares? The average MediPharm Labs Corp. stock forecast 2025 represents a -18.05% decrease from the last price of 0.49. About MediPharm Labs. View analysts' price targets for MediPharm Labs or view top-rated stocks among Wall Street analysts. Get the latest stock price for MediPharm Labs Corp. (LABS), plus the latest news, recent trades, charting, insider activity, and analyst ratings. MediPharm Labs Achieves Ships Cannabis Oil From Australia to Germany, an Export Milestone. 04/06. Currency in USD.